Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
JNJ News
Johnson & Johnson (NYSE:JNJ) said that data from late-stage studies showed that its oral medication, icotrokinra, was more effective compared with Bristol Myers...
Johnson & Johnson announced new data from the Phase 3 Iconic-Advance 1 and 2 studies which assessed the superiority of icotrokinra, a first-in-class investigati...
JPMorgan raised the firm’s price target on Johnson & Johnson to $195 from $185 and keeps a Neutral rating on the shares. The firm left its large cap biopharma e...
Analyst ratings
58%
of 26 ratingsMore JNJ News
Shanghai Henlius Biotech (OTCPK:SGBCF) is in talks with pharmaceutical giants such as Johnson & Johnson (JNJ) and Roche Holding AG (OTCQX:RHHBY) about selling t...
In the past week, Johnson & Johnson announced FDA approval of INLEXZO for BCG-unresponsive non-muscle invasive bladder cancer and published Phase 3 MARIPOSA stu...
Despite ongoing legal battles related to its talc products, Johnson & Johnson JNJ stock has climbed over 23% year-to-date. CNBC’s Jim Cramer on Thursday attrib...
On Tuesday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson's JNJ Inlexzo (gemcitabine intravesical system) as a new treatment approach f...
